Drug recall · November 25, 2020
Hydrocodone Bitartrate and Acetaminophen Tablets recall
Why: Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc. Central Islip, NY 11722, NDC 31722-943-01
- Lots / codes
Lot #: 20070518, Exp. Date June 2022
- Quantity
- 9768 Bottles
- Company
- Ascent Pharmaceuticals, Inc., Central Islip, NY
- Distribution
- Nationwide within the United States
- Initiated
- October 26, 2020 · Voluntary: Firm initiated
- Classified
- November 17, 2020
- Reported
- November 25, 2020
- Ended
- February 17, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrocodone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.